NUDT1 and cancer: However, TH588-induced anti-tumour effects may also be MTH1-dependent8, creating an apparent paradox in the literature on the role of MTH1 as valid target for therapy, and the use of its inhibitors in cancer treatment15–19 as reviewed elsewhere14.